{"transactions":[{"id":741961,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T20:31:30.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":49000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the terms of the Merger Agreement, each share of Company Common Stock subject to issuance pursuant to outstanding restricted stock units (each, a \"Company RSU Award\"), that was outstanding immediately prior to the Effective Time, became fully vested, and was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the Merger Consideration multiplied by (B) the number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on April 16, 2026, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on April 16, 2026, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001959750-26-000003","document":"form4-06112026_080626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1959750/000195975026000003/form4-06112026_080626.xml","form_type":"4"}},{"id":741960,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:31:30.000Z","date":"2026-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2026 (the \"Merger Agreement\"), by and among KalVista Pharmaceuticals, Inc., a Delaware corporation (the \"Issuer\" or the \"Company\"), Chiesi Farmaceutici S.p.A., an Italian societa per azioni (\"Parent\"), and Skyline Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, Merger Sub completed a cash tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Company Common Stock\"), for a price per share of $27.00 (the \"Merger Consideration\"), without interest, less any applicable tax withholding. Effective as of June 11, 2026, Merger Sub merged with and into the Company with the Company surviving the Merger as a wholly owned subsidiary of the Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase shares of Company Common Stock (\"Company Option\") that was outstanding and unexercised immediately prior to the effective time of the Merger (the \"Effective Time\") and had a per share exercise price that was less than the Merger Consideration became fully vested, was cancelled and converted into the right of the holder thereof to receive a cash payment (without interest) equal to the product of (A) the excess of (x) the Merger Consideration over (y) the per share exercise price of such Company Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time. Each Company Option that was outstanding and unexercised immediately prior to the Effective Time and had a per share exercise price that is equal to or greater than the Merger Consideration was automatically cancelled for no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a 4-year period: 25% on October 8, 2026, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":11.49,"expiration_date":"2035-10-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001959750-26-000003","document":"form4-06112026_080626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959750/000195975026000003/form4-06112026_080626.xml","form_type":"4"}},{"id":934394,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-21T21:11:45.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 22, 2026, for so long as grantee's Service (as defined in the Plan) does not terminate."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 22, 2026, for so long as grantee's Service (as defined in the Plan) does not terminate."}],"balance_after":49000,"derivative":{"underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001959750-26-000001","document":"form4-01212026_090142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959750/000195975026000001/form4-01212026_090142.xml","form_type":"4"}},{"id":1021606,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-08T22:59:33.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 4-year period: 25% vests on October 8, 2026, after which 1/48th of the total shares vest monthly, subject to reporting person's continued service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":11.49,"expiration_date":"2035-10-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001959750-25-000006","document":"form4-10082025_101030.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1959750/000195975025000006/form4-10082025_101030.xml","form_type":"4"}},{"id":1073484,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Stock Units","published_at":"2025-08-07T00:03:04.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-104399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025104399/ownership.xml","form_type":"4"}},{"id":1213606,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:08.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037524/ownership.xml","form_type":"4"}},{"id":1213605,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:08.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0000950170-25-037524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037524/ownership.xml","form_type":"4"}},{"id":1213604,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:08.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":523,"price":100.13,"value":52367.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":24224,"source":{"system":"sec-edgar","filing":"0000950170-25-037524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037524/ownership.xml","form_type":"4"}},{"id":1216317,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Stock Units","published_at":"2025-03-11T00:00:03.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-036691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036691/ownership.xml","form_type":"4"}},{"id":1216316,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:03.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":8527,"price":103.7,"value":884249.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023."}],"balance_after":24747,"source":{"system":"sec-edgar","filing":"0000950170-25-036691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036691/ownership.xml","form_type":"4"}},{"id":1216315,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:03.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":508,"price":103.7,"value":52679.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":33274,"source":{"system":"sec-edgar","filing":"0000950170-25-036691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036691/ownership.xml","form_type":"4"}},{"id":1216314,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:03.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":33782,"source":{"system":"sec-edgar","filing":"0000950170-25-036691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036691/ownership.xml","form_type":"4"}},{"id":1220722,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:08.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":233,"price":101.34,"value":23612.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":16282,"source":{"system":"sec-edgar","filing":"0000950170-25-035005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035005/ownership.xml","form_type":"4"}},{"id":1220721,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:08.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":101.34,"value":28476.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":16515,"source":{"system":"sec-edgar","filing":"0000950170-25-035005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035005/ownership.xml","form_type":"4"}},{"id":1232458,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:08.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":719,"price":103.77,"value":74610.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 152 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025."}],"balance_after":16796,"source":{"system":"sec-edgar","filing":"0000950170-25-032761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025032761/ownership.xml","form_type":"4"}},{"id":1270398,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2025-02-14T01:00:03.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-020191","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025020191/ownership.xml","form_type":"4"}},{"id":1470000,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-21","kind":"exercise","planned":true,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469999,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-21","kind":"grant","planned":true,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469998,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":3898,"price":163.23,"value":636270.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."}],"balance_after":17363,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469997,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":224,"price":167.13,"value":37437.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.91 to $167.36, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":21261,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469996,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":700,"price":166.1,"value":116270.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.69  to $166.44, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":21485,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469995,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":300,"price":164.61,"value":49383.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.38 to $164.91, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":22185,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469994,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":1055,"price":163.83,"value":172840.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.35 to $164.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":22485,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469993,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":5580,"price":162.31,"value":905689.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.25 to $163.21, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":23540,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469992,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":2352,"price":164.64,"value":387233.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024."}],"balance_after":29120,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1469991,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:02.000Z","date":"2024-06-21","kind":"exercise","planned":true,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":31472,"source":{"system":"sec-edgar","filing":"0000950170-24-077518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077518/ownership.xml","form_type":"4"}},{"id":1585305,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:24.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":472,"price":123.14,"value":58122.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":25222,"source":{"system":"sec-edgar","filing":"0000950170-24-029533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029533/ownership.xml","form_type":"4"}},{"id":1585304,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:24.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":506,"price":120.49,"value":60967.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":25694,"source":{"system":"sec-edgar","filing":"0000950170-24-029533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029533/ownership.xml","form_type":"4"}},{"id":1592834,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-07T01:00:10.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":237,"price":125.32,"value":29700.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":26200,"source":{"system":"sec-edgar","filing":"0000950170-24-027494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024027494/ownership.xml","form_type":"4"}},{"id":1592833,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-07T01:00:10.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":285,"price":125.32,"value":35716.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":26437,"source":{"system":"sec-edgar","filing":"0000950170-24-027494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024027494/ownership.xml","form_type":"4"}},{"id":1599786,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":12500,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1599785,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":114,"price":126.19,"value":14385.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024."}],"balance_after":26722,"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1599784,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":457,"price":129.71,"value":59277.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":26836,"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1599783,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":1543,"price":128.58,"value":198398.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":27293,"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1599782,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":28836,"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1599781,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:28.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":251,"price":126.19,"value":31673.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024."}],"balance_after":22836,"source":{"system":"sec-edgar","filing":"0000950170-24-026606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026606/ownership.xml","form_type":"4"}},{"id":1722773,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-12-06T01:00:13.000Z","date":"2023-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3682,"price":80.34,"value":295811.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2023."}],"balance_after":22886,"source":{"system":"sec-edgar","filing":"0001209191-23-057558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123057558/doc4.xml","form_type":"4"}},{"id":1930520,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:00:09.000Z","date":"2023-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":307,"price":136.66,"value":41954.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 29, 2019."}],"balance_after":26367,"source":{"system":"sec-edgar","filing":"0001209191-23-023064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123023064/doc4.xml","form_type":"4"}},{"id":1959851,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-11T01:00:11.000Z","date":"2023-03-08","kind":"tax_withholding","acquired":false,"shares":314,"price":153.19,"value":48101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":26674,"source":{"system":"sec-edgar","filing":"0001209191-23-018018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123018018/doc4.xml","form_type":"4"}},{"id":1964309,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:57.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":27000,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-017403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017403/doc4.xml","form_type":"4"}},{"id":1964308,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:57.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":26988,"source":{"system":"sec-edgar","filing":"0001209191-23-017403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017403/doc4.xml","form_type":"4"}},{"id":1964307,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:57.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":154,"price":157.21,"value":24210.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":22488,"source":{"system":"sec-edgar","filing":"0001209191-23-017403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017403/doc4.xml","form_type":"4"}},{"id":1964306,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:57.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":186,"price":157.21,"value":29241.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":22642,"source":{"system":"sec-edgar","filing":"0001209191-23-017403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017403/doc4.xml","form_type":"4"}},{"id":1976465,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-04T01:01:02.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":172,"price":147.57,"value":25382.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 163 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2023."}],"balance_after":22828,"source":{"system":"sec-edgar","filing":"0001209191-23-016058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123016058/doc4.xml","form_type":"4"}},{"id":1976464,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Common Stock","published_at":"2023-03-04T01:01:02.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":80,"price":147.57,"value":11805.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."}],"balance_after":22837,"source":{"system":"sec-edgar","filing":"0001209191-23-016058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123016058/doc4.xml","form_type":"4"}},{"id":2070481,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":39324,"kind":"person","name":"Arif Bilal","position":1,"cik":"0001959750","reported_name":"Arif Bilal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech Ops Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T01:03:05.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":129.58,"exercise_date":"2023-12-31","expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-001464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123001464/doc4.xml","form_type":"4"}}]}